Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Steetskamp, J.; Treiber, L.; Roedel, A. et al.
Post-traumatic stress disorder following childbirth: prevalence and associated factors-a prospective cohort studyARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 306. H. 5. 2022 S. 1531-1537
Schwab, Roxana; Stewen, Kathrin; Ost, Laura et al.
Predictors of Psychological Distress in Women with Endometriosis during the COVID-19 PandemicINTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. Bd. 19. H. 8. 2022
Hofmann, Konstantin; Macchiella, Doris; Kloeckner, Roman et al.
Pregnancy management for a woman with extensive vulvar and pelvic malformations caused by Klippel-Trenaunay syndromeCLINICAL CASE REPORTS. Bd. 10. H. 7. 2022
Heimes, A-S; Krajnak, S.; Almstedt, K. et al.
Prognostic impact of LAG-3 expression in early breast cancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 82. H. 10. 2022 S. E85-E85
Heimes, Anne-Sophie; Almstedt, Katrin; Krajnak, Slavomir et al.
Prognostic Impact of LAG-3 mRNA Expression in Early Breast CancerBIOMEDICINES. Bd. 10. H. 10. 2022
Bartlett, J. M.; Xu, K.; Wong, J. et al.
Prognostic performance of Breast Cancer Index (BCI) in postmenopausal women with early-stage HR plus breast cancer in the TEAM trialANNALS OF ONCOLOGY. Bd. 33. H. 7. 2022 S. S602-S602
Harter, Philipp; Sehouli, Jalid; Vergote, Ignace et al.
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer (vol 385, pg 2123, 2021)NEW ENGLAND JOURNAL OF MEDICINE. Bd. 386. H. 7. 2022 S. 704-704
Lueftner, Diana; Brucker, Cosima; Decker, Thomas et al.
Real-world efficacy of ribociclib (RIB) plus aromatase inhibitor (AI)/fulvestrant (FUL), or endocrine monotherapy (ET), or chemotherapy (CT) as first-line (1L) treatment (tx) in patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC): Results of fourth interim analysis (IA) from RIBANNA.JOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 16. 2022
Luftner, Diana; Brucker, Cosima; Decker, Thomas et al.
Real-world efficacy of ribociclib plus aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with hormone receptor-positive (HR plus ), human epidermal growth factor receptor-2-negative (HER2-) locally advanced or metastatic breast cancer: Fourth interim analysis from the RIBANNA studyCANCER RESEARCH. Bd. 82. H. 4. 2022
Schwab, Roxana; Droste, Annika; Stewen, Kathrin et al.
Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 PandemicINTERNATIONAL JOURNAL OF GENERAL MEDICINE. Bd. 15. 2022 S. 7039-7052